Form 4 for SAFT SAFETY INSURANCE GROUP INC
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-25 · accession 0001415889-25-006433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-02-25 | SAFT | McConnell Mary Frances | VP of Underwriting | J - Other | $0.00 | -175 | 3,736 | -4% | $0 | |
| M | 2025-03-04 | 2025-02-25 | SAFT | McConnell Mary Frances | VP of Underwriting | A - Grant | $0.00 | +3,068 | 6,804 | +82% | $0 |
| M | 2025-03-04 | 2025-02-25+ | SAFT | McConnell Mary Frances | VP of Underwriting | F - Tax | $76.74 | -328 | 6,795 | -5% | -$25.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | J | D | 175 | $0.00 | 3,736 | D | — | — | (F1) Represents the difference between performance shares, with a three year performance period, that were granted on February 23, 2022 and actual shares earned at the end of the performance period on December 31, 2024. Final shares were approved by the Compensation Committee on February 25, 2025. |
| 2 | Common | Common Stock | 2025-02-25 | A | A | 1,412 | $0.00 | 5,148 | D | — | — | (F2) Represents restricted stock awards effective February 25, 2025, with respect to which sale or transfer rights shall vest over three years with installments of 30% on February 25, 2026, 30% on February 25, 2027, and the remaining 40% on February 25, 2028, provided the grantee meets certain employment conditions. |
| 3 | Common | Common Stock | 2025-02-25 | A | A | 1,656 | $0.00 | 6,804 | D | — | — | (F3) Represents restricted stock awards granted effective February 25, 2025 with respect to which sale or transfer rights will vest over a three-year performance period commencing on January 1, 2025 and ending on December 31, 2027. Vesting of these shares is dependent upon the attainment of pre-established performance objectives, and any difference between shares granted and shares earned at the end of the performance period will be reported at the conclusion of the performance period in 2028. |
| 4 | Common | Common Stock | 2025-02-25 | F | D | 2 | $77.48 | 6,802 | D | — | — | (F4) Represents securities delivered in payment of a tax liability with respect to vesting of securities issued in accordance with Rule 16b-3. (F5) Securities sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2024. |
| 5 | Common | Common Stock | 2025-02-28 | F | D | 89 | $76.37 | 6,476 | D | — | — | (F4) Represents securities delivered in payment of a tax liability with respect to vesting of securities issued in accordance with Rule 16b-3. (F5) Securities sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2024. (F10) Represents the weighted average sale price of multiple open market same day sales with prices ranging from $75.65 to $76.65 per share. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission or a security holder of the issuer upon request. |
| 6 | Common | Common Stock | 2025-02-25 | F | D | 76 | $79.53 | 6,719 | D | — | — | (F4) Represents securities delivered in payment of a tax liability with respect to vesting of securities issued in accordance with Rule 16b-3. (F5) Securities sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2024. (F7) Represents the weighted average sale price of multiple open market same day sales with prices ranging from $79.15 to $79.95 per share. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission or a security holder of the issuer upon request. |
| 7 | Common | Common Stock | 2025-02-27 | F | D | 46 | $75.48 | 6,673 | D | — | — | (F4) Represents securities delivered in payment of a tax liability with respect to vesting of securities issued in accordance with Rule 16b-3. (F5) Securities sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2024. (F8) Represents the weighted average sale price of multiple open market same day sales with prices ranging from $75.43 to $76.20 per share. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission or a security holder of the issuer upon request. |
| 8 | Common | Common Stock | 2025-02-28 | F | D | 108 | $75.48 | 6,565 | D | — | — | (F4) Represents securities delivered in payment of a tax liability with respect to vesting of securities issued in accordance with Rule 16b-3. (F5) Securities sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2024. (F9) Represents the weighted average sale price of multiple open market same day sales with prices ranging from $75.19 to $75.64 per share. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission or a security holder of the issuer upon request. |
| 9 | Common | Common Stock | 2025-02-25 | F | D | 7 | $78.49 | 6,795 | D | — | — | (F4) Represents securities delivered in payment of a tax liability with respect to vesting of securities issued in accordance with Rule 16b-3. (F5) Securities sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2024. (F6) Represents the weighted average sale price of multiple open market same day sales with prices ranging from $78.40 to $78.72 per share. Full information regarding the number of shares sold at each separate price will be provided to the Securities and Exchange Commission or a security holder of the issuer upon request. |